Moody’s affirms ‘A2’ rating for University of Maryland Medical System

Moody’s Investors Service affirmed its “A2” rating for the Baltimore-based University of Maryland Medical System, affecting $1.1 billion of outstanding debt.

Advertisement

The rating favorably acknowledges that the system’s strong brand and leadership position, combined with its substantial geographic reach, will continue to lead to a notable market share and high patient demand. However, the rating will remain constrained by a modest balance sheet, a competitive operating environment and significant capital spending plans.

The rating outlook remains negative.

More articles on healthcare finance:

Utilities won’t be shut off at Kansas hospital
California budget calls for healthcare spending boost
Bulk pricing of healthcare services saves time, money, business owner says

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.